Grammy-winning soul vocalist D’Angelo passed away on October 14 at age 51 after a private battle with pancreatic cancer.
“The shining star of our family has dimmed his light for us in this life,” his relatives confirmed. “After a prolonged and brave struggle with cancer, we are heartbroken to announce that Michael D’Angelo Archer, recognized by his followers around the world as D’Angelo, has been taken from us.”
D’Angelo left an indelible mark on the music industry with his pioneering neo-soul sound and partnerships with high-profile artists.
He released his debut album, “Brown Sugar,” in 1995 to instant praise. The record reached No. 4 on the R&B charts, went platinum later that year, and earned multiple Grammy nominations.
However, it was his sophomore release, “Voodoo,” in 2000 that boosted his music career into the stratosphere. The record premiered at the top spot on each of Billboard’s Top R&B Albums chart and the main album chart. He received two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”
The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction featured the singer, famously bare to his midsection, singing straight into the camera.
D’Angelo retreated from the spotlight after releasing Voodoo and publicly struggled with substance abuse. In 2005, he was part of a serious vehicle accident that put him in critical condition.
More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with another No. 1 debut on the R&B chart and a award for Top R&B Record.
Again, in his own enigmatic way, D’Angelo had limited public outings in the subsequent period.
The singer was scheduled as a top act for the 2025 Roots Picnic festival, but his performance was canceled, due to an “unexpected health issue.”
Even though details are sparse about D’Angelo’s health in the weeks leading up to his passing, he had apparently been in the hospital for an extended period and in hospice for two weeks.
D’Angelo’s passing is a clear example of the harmful impact of pancreatic cancer, one of the deadliest and hardest to prevent forms of the disease, on a gifted artist whose existence was ended too soon.
“We are saddened that he can only leave dear memories with his loved ones, but we are eternally grateful for the heritage of deeply emotional music he leaves behind,” his family said.
Pancreatic malignancy affects the pancreas, a small organ that produces insulin and is vital in digestion, among other functions. The position and dimensions of the organ in the human system make it more challenging to detect malignancy.
Even though this cancer accounts for only about 3% of cancer diagnoses each year in the United States, it is causes 7% of cancer deaths.
Almost seventy thousand people will be found to have this condition and about fifty-two thousand will die of the illness in 2025.
“This malignancy is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have few and poor therapies, and a narrow opportunity to make a significant difference on the lives of people,” noted a medical oncologist.
Since pancreatic cancer rarely causes early symptoms, it’s often identified only after the disease is late-stage. Although a individual has indicators they are usually nonspecific and may be mistaken for a number of everyday ailments.
“Currently, there is no good way to identify pancreatic cancer in the initial phases, except for listening to your body and consulting your doctor if there are unfamiliar symptoms,” said a health expert.
Common symptoms of pancreatic cancer encompass:
At age 51, D’Angelo’s demise is an outlier, as this malignancy is typically found in individuals in the sixty-five to seventy-five age bracket. However, numerous malignancies, such as this type, have become increasingly prevalent in younger adults.
“Pancreatic cancer diagnosed before the age of 50 is considered uncommon, yet concerningly, doctors are noticing a rising count of younger patients affected by this condition,” said a expert.
In the absence of effective screening tools for this malignancy, professionals stressed the significance of understanding your family’s health background. Some risk factors, such as tobacco use and obesity also play a role in the development of pancreatic cancer.
African Americans have the greatest occurrence of this malignancy in the United States and are more prone to be diagnosed with untreatable disease.
“The first step toward reducing one’s chance of this condition is assessing individual susceptibility. People should examine their family history, genetic background, and medical conditions, such as blood sugar disease, chronic pancreatitis, or obesity that may increase their vulnerability,” advised a medical professional.
Hereditary elements are associated with as much as ten percent of all this malignancy instances. If someone in your household has had this disease, you may want to think about DNA analysis.
“For people with a family history of this condition or those having high risk genetic mutations, checking may involve advanced imaging such as MRI scans or endoscopic ultrasound (EUS) to detect initial alterations in the pancreas,” he explained.
For those wishing to lower their chance, lifestyle changes may make a difference. The most effective step you can take to reduce your susceptibility of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.
Heavy drinking is linked to pancreatitis, a risk factor for this malignancy, so reducing or avoiding alcohol may assist reduce your risk.
Controlling your weight or shedding pounds may also aid reduce your risk. Individuals with excess weight are twenty percent more prone to get this disease. This malignancy also is more frequent in people with diabetes, and reducing weight can also lower the risk of type 2 diabetes.
Despite pancreatic cancer’s grim outlook, there is still hope.
“We are doing better with treatments and newer combination chemotherapy. There are emerging precision medicines that already are making an impact,” said a specialist.
For many individuals, however, awareness about this uncommon but {dev
A tech strategist and writer passionate about digital transformation and emerging technologies.